Suppr超能文献

右美托咪定与纳布啡联合应用于腹腔镜胃癌根治术中。

Combined use of dexmedetomidine and nalbuphine in laparoscopic radical gastrectomy for gastric cancer.

作者信息

Zhao Guo-Guang, Lou Chao, Gao Rong-Lei, Lei Fu-Xing, Zhao Jing

机构信息

Department of Anesthesiology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong Province, China.

Department of Dermatology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong Province, China.

出版信息

World J Gastrointest Oncol. 2024 Jul 15;16(7):2952-2959. doi: 10.4251/wjgo.v16.i7.2952.

Abstract

BACKGROUND

Radical laparoscopic gastrectomy is an important treatment modality for gastric cancer. Surgery requires general anesthesia, and patients are susceptible to the effects of anesthetic drugs and carbon dioxide insufflation during the procedure, leading to inflammation or severe pain, which can affect patient outcome.

AIM

To explore the efficacy of combining dexmedetomidine (DEX) with nalbuphine in patients underwent laparoscopic radical gastrectomy for gastric cancer.

METHODS

Patients scheduled to undergo laparoscopic radical gastrectomy were selected and randomly assigned to A or B group. In A group, patients received an intravenous injection of nalbuphine 0.2 mg/kg + DEX 0.4 μg/kg 10 min before the end of surgery; in B group, patients received only an intravenous injection of nalbuphine. The trends in hemodynamic parameter fluctuations, awakening quality during the recovery period, serum inflammatory markers, agitation scores, cough severity, incidence, and duration of postoperative delirium (POD) were compared.

RESULTS

The mean arterial pressure and heart rate in the A group were more stable ( < 0.05). The A group had a lower average awakening time, extubation time, and agitation scores during recovery than the B group. Agitation control in the A group was more effective at different time points ( < 0.05). Patients in the A group had lower serum interleukin (IL)-6, tumour necrosis factor alpha, and IL-10 levels at 1 h after surgery than the B group. The incidence of coughing and duration of POD were lower and shorter in the A group than in the B group. Adverse reactions caused by the two anesthesia methods were less frequent in the A group than in the B group ( < 0.05).

CONCLUSION

The use of DEX and nalbuphine in patients undergoing laparoscopic radical gastrectomy for gastric cancer help reducing the inflammatory response, cough severity, and agitation and helps maintain hemodynamic stability.

摘要

背景

腹腔镜根治性胃切除术是胃癌的重要治疗方式。手术需要全身麻醉,术中患者易受麻醉药物和二氧化碳气腹的影响,导致炎症或剧痛,进而影响患者预后。

目的

探讨右美托咪定(DEX)与纳布啡联合应用于腹腔镜根治性胃癌切除术患者的疗效。

方法

选取拟行腹腔镜根治性胃切除术的患者,随机分为A组和B组。A组患者在手术结束前10分钟静脉注射纳布啡0.2mg/kg + DEX 0.4μg/kg;B组患者仅静脉注射纳布啡。比较两组患者血流动力学参数波动趋势、恢复期苏醒质量、血清炎症标志物、躁动评分、咳嗽严重程度、术后谵妄(POD)的发生率及持续时间。

结果

A组平均动脉压和心率更稳定(P<0.05)。A组患者恢复期平均苏醒时间、拔管时间及躁动评分均低于B组。A组在不同时间点的躁动控制更有效(P<0.05)。A组患者术后1小时血清白细胞介素(IL)-6、肿瘤坏死因子α和IL-10水平低于B组。A组咳嗽发生率及POD持续时间低于B组且更短。A组两种麻醉方法引起的不良反应发生率低于B组(P<0.05)。

结论

DEX与纳布啡用于腹腔镜根治性胃癌切除术患者有助于减轻炎症反应、咳嗽严重程度及躁动,并有助于维持血流动力学稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/113a/11271771/49af297d5e7d/WJGO-16-2952-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验